Penn, CHOP researchers call study results of cell therapy in leukemia patients 'unprecedented'

An experimental cellular therapy developed at the Perelman School of Medicine at the University of Pennsylvania achieved complete remission in 90 percent of the clinical study patients with acute lymphoblastic leukemia who have received the treatment...